公开(公告)号：US20220323443A1

公开(公告)日：2022-10-13

申请号：US17627857

申请日：2020-07-17

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Akihiro Ohashi ,  Kenichi Iwai ,  Tadahiro Nambu ,  Jie Yu ,  Kurt Eng ,  Michael Joseph Kuranda ,  Kazuho Nishimura ,  Cong Li

IPC: A61K31/519 ,  A61K31/555 ,  A61K45/06 ,  A61P35/00

Abstract: The present disclosure relates to the treatment of cancer using a combination therapy comprising Compound 1 and/or tautomers thereof or a pharmaceutically acceptable salt or hydrate thereof, and a second therapy.